Healius Limited announced the appointment of Dr. Jan Van Rooyen to the role of Group Executive, Healius Pathology effective from 1 June 2023. Dr. Van Rooyen replaces Mr. John McKechnie who will step down from a full-time role on 30 June 2023 and remain in an advisory capacity as he transitions to retirement. Dr. Van Rooyen is both a Pathologist and a business leader and was the Chief Executive Officer of AMPATH in South Africa for nearly 20 years.

Under Dr. Van Rooyen's leadership, AMPATH was transformed clinically and operationally from a collection of independent practices to a market-leading nationally consolidated business with a common support and IT infrastructure. Dr. Van Rooyen will be supported by Mr. Ian McPhan, the Chief Operating Officer, and by the highly- qualified clinical and operational teams at Healius Pathology. Together with Dr. Phil Lucas who is the Group Executive, Lumus Imaging and was one of the founders of PRP Diagnostic Imaging, Healius has good operational bench strength to deliver on the next generation diagnostics strategy and growth agenda.